News Center
As of August 15, 2026, the EU REACH compliance requirements for metal-amino acid chelates have undergone a direct change. According to a notice issued by the European Chemicals Agency (ECHA) on August 4, 2026, these substances have been included in the mandatory pre-registration scope under Article 10 of the REACH Regulation. This involves manufacturers and importers exporting relevant products to the EU and will also affect overseas distribution, order fulfillment, and market access. For Chinese exporters of amino acid chelates, the key point of this development is not merely the addition of a new rule, but that failure to complete pre-registration will directly affect whether products can continue to enter the EU market legally.
The confirmed information shows that the European Chemicals Agency (ECHA) issued a notice on August 4, 2026, bringing metal-amino acid chelates within the mandatory pre-registration scope under Article 10 of the REACH Regulation. Examples include products such as zinc glycinate and copper lysinate. According to the notice, all manufacturers and importers exporting such products to the EU must complete substance pre-registration by August 15, 2026. Those failing to do so will be unable to place the products on the EU market legally. Based on the information provided, this requirement will directly affect the compliant market access pathways of Chinese exporters and overseas distributors of amino acid chelates.
The analysis indicates that manufacturers and export trading companies supplying the EU directly will be affected first. This is because the pre-registration requirement directly determines eligibility to place products on the market, with the main points of impact involving substance compliance confirmation, preparation before customs declaration, order scheduling, and customer delivery arrangements. For these companies, the current priorities are to determine whether their own export product categories fall within the scope of the notice and whether existing EU business faces interruption risks due to the status of pre-registration.
From the perspective of business roles, EU importers and overseas distributors will also be significantly affected. Their primary pressure is not on the production side, but on channel access and the assessment of the legality of continued sales. If the upstream supplied substances have not completed pre-registration, the import and distribution chain may be unable to proceed. As a result, this change will prompt channel stakeholders to pay closer attention to suppliers' compliance status, document completeness, and delivery feasibility.
Although the notice is directly aimed at manufacturers and importers, its actual impact will not remain limited to a single party. Supply chain service activities related to EU orders, including document coordination, shipment schedule confirmation, customer communication, and contingency planning for exceptions, will all be affected. Especially with the effective date approaching, all participants in the fulfillment chain need to establish a consistent assessment of whether pre-registration has been completed; otherwise, delays or rework may occur during execution.
From a practical perspective, companies should first verify whether the products they export to the EU fall within the scope of metal-amino acid chelates. Since the notice specifically mentions categories such as zinc glycinate and copper lysinate, relevant companies should prioritize reviewing their existing product catalogs, customer orders, and shipments in transit to avoid understanding the rule only at a conceptual level.
The analysis indicates that the most common problem with this type of regulatory change is that companies know the rules have changed but fail to promptly convert the change into concrete business actions. For parties involved in EU business, the focus is not only on knowing that the notice was issued on August 4, but also on returning to the clear requirement of completing pre-registration by August 15 and determining whether existing orders, planned shipment batches, and newly contracted business can continue to be executed.
For exporters, importers, and distribution channels, a practical issue requiring attention is whether supplier qualifications and document preparation can support subsequent fulfillment. The analysis indicates that communication regarding the pre-registration requirement should be initiated as early as possible, including confirmation of upstream supply status, compliance explanations for customers, and contingency planning for possible changes to delivery schedules.
Because the information provided in this input only confirms the notice date, the covered parties, the example substances, and the requirement to complete pre-registration before the effective date, companies still need to continue monitoring subsequent official statements during implementation. In particular, further updates on the specific scope of application, interpretation of documentation requirements, and actual filing arrangements may continue to affect companies' internal assessments and the pace of external communication.
From an editorial perspective, this information is more appropriately understood as a signal that tightened compliance requirements have entered the implementation stage, rather than simply as an indication of policy direction. This is because the information provided not only identifies the regulated entities and covered categories, but also clearly states that pre-registration must be completed by August 15, otherwise the products cannot be legally placed on the EU market. At the same time, whether this will further affect broader category management, customer purchasing preferences, or channel structures remains an industry development requiring continued observation, and no broader definitive conclusions can yet be drawn.
Overall, the direct significance of this change is that the compliance threshold for amino acid chelate products entering the EU market has been moved forward. Market access is no longer only a matter of shipment or customs clearance, but must be addressed earlier through substance pre-registration preparation. For relevant companies and industry professionals, it is currently more appropriate to regard this as a compliance matter that must be handled in the short term, as well as a regulatory signal worth continuing to track. Its subsequent impact will still depend on how companies implement the requirements and on the release of further official information.
This article was generated based on the information title, event date, and event summary provided by the user. The confirmed facts include that the European Chemicals Agency (ECHA) issued a notice on August 4, 2026; that metal-amino acid chelates were included in the mandatory pre-registration scope under Article 10 of the REACH Regulation; that relevant manufacturers and importers must complete pre-registration by August 15, 2026; that those failing to complete it cannot legally place the products on the EU market; and that this directly affects the compliance pathways of Chinese exporters and overseas distributors. In terms of the types of information sources typically associated with such information, they may include official announcements, corporate announcements, industry association information, authoritative media reports, and documents issued by standards organizations. However, no specific official source link was provided in this input, so further verification is still required. The main areas requiring continued attention include subsequent official statements, the specific scope of application, and changes in the implementation of actual business operations by companies.
Listen to every customer's voice